CLINICAL_TRIALS
research
· 2025-09-18
Clinical Trial Update: Global Trial in APG2575 for Patients With CLL/SLL [Phase 3]
Summary
Global Phase 3 trial of APG2575 in chronic lymphocytic leukemia and small lymphocytic lymphoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ascentage Pharma Group Inc. | Conditions: CLL/SLL | Phase 3 | Status: RECRUITING